Drug
Armodafinil
Armodafinil: highest development phase Post-Market, developed by Teva. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Armodafinil NCT01080807 | Post-Market | Excessive Sleepiness |
| Armodafinil NCT00078377 | Phase 3 | Narcolepsy |
| Armodafinil NCT00893789 | Phase 3 | Traumatic Brain Injury |
Latest
No recent events.
Follow Armodafinil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.